Followers | 183 |
Posts | 7856 |
Boards Moderated | 0 |
Alias Born | 02/06/2010 |
Wednesday, January 21, 2015 11:09:41 AM
William Katz of Citigroup on Tuesday maintained a Sell/High Risk rating on shares of FXCM Inc (NYSE: FXCM) with a price target lowered by $4.25 to $0.75 following details that emerged over the weekend of Leucadia's $300 million rescue package.
Katz notes that the “onerous” terms include an annual interest rate of 10 percent, increasing by 1.5 percent per annum each quarter, up to 17 percent. The loan is also subject to mandatory repayments and restructure covenants.
Katz states that the company will likely never achieve its prior market cap of $1.3 billion (now estimated at around $50 million to $68 million), even assuming a possible sale to a strategic buyer. The analyst adds that based on the disclosure, FXCM will try to sell itself by April 2015
http://finance.yahoo.com/news/citigroup-reduces-fxcms-price-target-143109364.html
North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM
One World Products, Inc. Issues Shareholder Update • OWPC • May 29, 2024 8:20 AM
Green Leaf Innovations, Inc. Engages Olayinka Oyebola & Co for Two-Year Audit • GRLF • May 28, 2024 8:30 AM
HealthLynked Introduces AI-Powered Chat Function to Enhance Healthcare Accessibility • HLYK • May 28, 2024 8:00 AM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM